Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer

Hulin-Curtis, Sarah, Petit, Dominique, Figg, W. Douglas, Hsing, Ann W. and Reichardt, Juergen K.V. 2010. Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer. Future Oncology 6 (12) , pp. 1897-1913. 10.2217/fon.10.149

Full text not available from this repository.

Abstract

Incidences of prostate cancer in most countries are increasing owing to better detection methods; however, prevention with the use of finasteride, a very effective steroid 5α-reductase type II inhibitor, has been met with mixed success. A wide interindividual variation in response exists and is thought to be due to heritable factors. This article summarizes the literature that attempts to elucidate the molecular mechanisms of finasteride in terms of its metabolism, excretion and interaction with endogenous steroid molecules. We describe previously reported genetic variations of steroid-metabolizing genes and their potential association with finasteride efficacy. Based on the literature, we outline directions of research that may contribute to understanding the interindividual variation in finasteride prevention and to the future development of personalized medicine.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Publisher: Future Medicine
ISSN: 1479-6694
Date of Acceptance: 1 November 2010
Last Modified: 04 Jun 2017 08:43
URI: http://orca-mwe.cf.ac.uk/id/eprint/83733

Citation Data

Cited 6 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item